Abstract
Prolonged, severe hypoglycemia is a critical obstacle in the care of patients with T1DM. Sensor-augmented insulin pump therapy with automated low glucose insulin suspension has potential to reduce the incidence of severe hypoglycemia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
